There are currently 45 active clinical trials seeking participants for Cancer research studies. The states with the highest number of trials for Cancer participants are .
Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis
Recruiting
This trial seeks to evaluate a management strategy after the acute treatment duration (≥ 3 months of therapeutic anticoagulation) for patients with cancer and catheter-related upper extremity deep vein thrombosis (DVT).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/26/2025
Locations: The Ottawa Hospital, Ottawa, Ontario
Conditions: Venous Thromboembolism, Cancer, Upper Extremity Deep Vein Thrombosis, Catheter-Related Infections
MR Imaging Study Using the Northern Alberta Linac-MR (Northern LIGHTs - 1)
Recruiting
Cancers are often treated with external beam radiotherapy. Current radiotherapy treatments are performed using computed tomography (also known as CT) scans which may not always clearly identify the cancer. In some instances, magnetic resonance imaging (MRI) may be able to better identify cancers. Therefore, efforts are currently underway to use the MRI scans to improve radiotherapy treatments or eventually even use radiotherapy equipment that only uses MRI scans to guide treatments. This new tec... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/09/2025
Locations: Cross Cancer Institute, Edmonton, Alberta
Conditions: Cancer
Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada
Recruiting
EXCEL will provide online and, where feasible, in-person exercise programs to individuals living with and beyond cancer (ILWBC). Research has shown that targeted programs that include tailored exercise prescriptions are more successful in helping individuals with chronic disease to incorporate physical activity and exercise into their daily routines. While ILWBC are advised by healthcare professionals (HCPs) to engage in exercise, there is a lack of cancer-specific exercise programs and cancer-t... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/28/2025
Locations: University of Calgary, Calgary, Alberta +4 locations
Conditions: Cancer, Prostate Cancers, Breast Cancers, Colon Cancer, Lung Cancers
Peer Support Group for Adolescent and Young Adult (AYA) Allogeneic Stem Cell Transplant Recipients
Recruiting
Allogeneic Haemopoietic Stem Cell Transplant (Allo-HSCT) is a potentially curative option for patients with both malignant and non-malignant hematological disorders. There appears to be unique experiences that adolescents and young adults (AYA) face when undergoing transplant. There is literature to suggest that peer support for young adults is associated with improvements in mental health including greater happiness, self-esteem and effective coping, as well as reductions in depression, lonelin... Read More
Gender:
ALL
Ages:
Between 18 years and 39 years
Trial Updated:
04/21/2025
Locations: Princess Margaret Cancer Centre, Toronto, Ontario
Conditions: Cancer, Leukemia, Stem Cell Transplant
Feasibility of Hyivy Device Post-Radiation for Pelvic Malignancies
Recruiting
Vaginal dilator therapy (VDT) with static dilators is often prescribed to patients following vaginal or pelvic radiation therapy. This study seeks to evaluate the feasibility of a novel intravaginal device that delivers patient-controlled dilation (Hyivy device). The study is designed as a proof-of-concept single-arm pilot study. The primary objective is to assess safety and tolerability, while also evaluating changes in health-related quality of life and pelvic pain.
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
04/17/2025
Locations: Grand River Regional Cancer Centre, Waterloo Regional Health Network @ Midtown, Kitchener, Ontario
Conditions: Vaginal Stenosis, Radiation Therapy, Cancer, Pelvic Pain, Pelvic Cancer
LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
Recruiting
People with advanced chronic cancers are now living for many years as a result of new targeted anti-cancer treatments. Many of these treatments are quite new and people may take them for months, even years, as long as the treatments are helping. The purpose of this study is to help understand how to best support people receiving these treatments.
Gender:
ALL
Ages:
Between 18 years and 90 years
Trial Updated:
04/14/2025
Locations: Edith Pituskin, Edmonton, Alberta
Conditions: Cancer, Tyrosine Kinase Mutation, Breast Cancer, Melanoma, Multiple Myeloma, Chronic Leukemia, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Lung Cancer
Comprehensive Health Assessment for My Plan: Initial Implementation Study (CHAMP Implementation Study)
Recruiting
The current standard preoperative assessment does not consider the needs of older adults undergoing non-oncological surgery. To enhance the treatment decision-making and planning for older adult surgical patients, the British Geriatric Society and the American Society of Colon and Rectal Surgeons recommend the implementation of preoperative GA for all older adults. Geriatric assessment (GA) predicts treatment toxicity and overall mortality in older adults with complex health problems. However, i... Read More
Gender:
ALL
Ages:
70 years and above
Trial Updated:
03/24/2025
Locations: University Health Network, Toronto, Ontario
Conditions: Cancer, Older Adults
The IMPACT Implementation-Effectiveness Trial
Recruiting
More Canadians are surviving cancer, however, individuals with cancer live with side effects for years after treatments have ended. The physical and psychosocial benefits of regular physical activity (PA) during and after cancer treatment are well established. However, less than 30% of individuals with cancer meet current PA recommendations and PA levels decline significantly during treatment. PA services within the cancer institution to support well-being during treatment are not available for... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/10/2025
Locations: Joseph Brant Hospital, Burlington, Ontario +2 locations
Conditions: Cancer
Behaviour Change for Cancer Survivors Trial
Recruiting
This study will be a two-arm, multi-site RCT, to examine the effects of an entirely virtual, 6-month supervised PA program plus standard exercise counselling (PA+EC) versus a supervised PA plus motivationally-enhanced behavioral counselling (PA+BC) on moderate to vigorous physical activity (MVPA) in cancer survivors. A 6-month post intervention follow-up (T2) and 1-year post intervention follow-up (T3; 1-year follow-up from post-intervention) will take place after the intervention to address mai... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/25/2025
Locations: University of British Columbia, Vancouver, British Columbia +1 locations
Conditions: Cancer, Exercise
Impact of PEG Bowel Preparation on Gut Microbiome Composition Recovery
Recruiting
The main objective is to evaluate the impact of intestinal preparation on the composition, diversity and metabolome of the intestinal microbiota.
Gender:
ALL
Ages:
Between 18 years and 70 years
Trial Updated:
02/17/2025
Locations: Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec
Conditions: Cancer, Healthy Participants
Activating Cancer Communities Through an Exercise Strategy for Survivors
Recruiting
Cancer continues to have the dubious honor of being the leading cause of premature mortality in Canada. The good news is, advances in early detection and cancer treatments are extending the lives of those diagnosed with the disease. However, as more people are living longer, the impact of the therapies used to treat the disease are becoming increasingly apparent. Ranging from the physiological to psychological, cancer survivors are often confronted with substantial, disabling, and life-threateni... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/13/2025
Locations: QEII Health Sciences Centre (Dickson Bldg), Halifax, Nova Scotia
Conditions: Cancer
Genomic Investigation of Unusual Responders
Recruiting
Studies have shown that tumors from the same patient may respond very differently to the same therapeutic agents. This study aims to investigate the genetic basis of tumors that respond abnormally well or poorly to therapeutic agents in an effort to understand the fundamental genetic basis of this response. The present protocol seeks to retrospectively perform Exome, next-generation (DNA) sequencing and/or other molecular techniques on tumor samples to identify the genetic basis of a patient's e... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/30/2025
Locations: Princess Margaret Cancer Centre, Toronto, Ontario
Conditions: Cancer, Breast Cancer, Non-small Cell Lung Cancer, Colorectal Cancer, Genitourinary Cancer, Gynecological Cancer, Upper Aerodigestive Tract Cancer, Pancreatobiliary Gastrointestinal Cancer, Melanoma (Skin), Rare Cancer, Carcinoma of Unknown Primary